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Summary
Protein trafficking through the secretory pathway plays a key role in epithelial organ development and function. The expansion of
tracheal tubes in Drosophila depends on trafficking of coatomer protein complex I (COPI)-coated vesicles between the Golgi complex
and the endoplasmic reticulum (ER). However, it is not clear how this pathway is regulated. Here we describe an essential function of
the Sec7 domain guanine nucleotide exchange factor (GEF) gartenzwerg (garz) in epithelial tube morphogenesis and protein secretion.
garz is essential for the recruitment of COPI components and for normal Golgi organization. A GFP–Garz fusion protein is distributed in
the cytoplasm and accumulates at the cis-Golgi. Localization to the Golgi requires the C-terminal part of Garz. Conversely, blocking the
GDP–GTP nucleotide exchange reaction leads to constitutive Golgi localization, suggesting that Garz cycles in a GEF-activity-
dependent manner between cytoplasmic and Golgi-membrane-localized pools. The related human ARF-GEF protein GBF1 can
substitute for garz function in Drosophila tracheal cells, indicating that the relevant functions of these proteins are conserved. We show
that garz interacts genetically with the ARF1 homolog ARF79F and with the ARF1-GAP homolog Gap69C, thus placing garz in a
regulatory circuit that controls COPI trafficking in Drosophila. Interestingly, overexpression of garz causes accumulation of secreted
proteins in the ER, suggesting that excessive garz activity leads to increased retrograde trafficking. Thus, garz might regulate epithelial
tube morphogenesis and secretion by controlling the rate of trafficking of COPI vesicles.
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Introduction
The dimensions and shapes of epithelial tubules in many organs,
such as vertebrate kidneys, lungs and vascular systems, are
precisely controlled to ensure normal organ function (Ghabrial
et al., 2003; Lubarsky and Krasnow, 2003; Baer et al., 2009).
However, the cellular and molecular mechanisms underlying tube
size control are not well understood. Recent work in various model
systems highlights the importance of membrane and protein
trafficking for the morphogenesis and function of epithelial tubes
(Datta et al., 2011). Genetic studies of tracheal development in
Drosophila revealed an important function of the secretory
apparatus for the expansion and functional maturation of tubular
epithelia. Tracheal tubes rapidly expand in diameter to attain their
functional dimensions at the end of embryogenesis (Beitel and
Krasnow, 2000). The diametric expansion (dilation) of the
tracheae depends on the transport of proteins into the lumen
(Tsarouhas et al., 2007). Although the precise roles of membrane
trafficking and of luminal components in tube expansion are not
yet clear, genetic mosaic analyses suggest that the diametric
expansion of the tracheal lumen is driven by a cell-autonomous
mechanism that promotes the enlargement of the apical cell
surface (Fo¨rster et al., 2010). Thus far, all genes known to be
required for tracheal lumen dilation encode components of the
early secretory apparatus. These genes encode components of the
anterograde (COPII) (Tsarouhas et al., 2007; Fo¨rster et al., 2010;
Norum et al., 2010) and the retrograde (COPI) (Grieder et al.,
2008; Jayaram et al., 2008) trafficking pathway between the ER
and the Golgi complex. Proteins exit the ER in COPII-coated
vesicles that subsequently fuse with the cis face of the Golgi
(reviewed by Lee et al., 2004; Sato and Nakano, 2007; Spang,
2009). To maintain organelle homeostasis, the flow of membranes
and proteins between the ER and Golgi has to be balanced. COPI-
coated vesicles retrieve ER-resident proteins from the Golgi and
the ER-Golgi intermediate compartment (ERGIC) and release
them back into the ER (reviewed by Hsu and Yang, 2009). The
formation of both COPII- and COPI-coated vesicles is regulated by
G-proteins of the ARF/SAR superfamily (reviewed by Gillingham
and Munro, 2007). COPI vesicle formation is initiated by the
conversion of inactive GDP-bound ARF1 to its active GTP-bound
form, as a result of the activity of a guanine nucleotide exchange
factor (GEF) (Peyroche et al., 1996). Following the exchange
reaction, ARF1-GTP undergoes a conformational change that
allows stable ARF1 membrane anchorage (Franco et al., 1996;
Antonny et al., 1997). This is thought to initiate the assembly of the
coatomer complex on the Golgi membrane that leads to the
budding of COPI-coated vesicles. ARF-GEF proteins share a
central conserved Sec7 domain that facilitates ARF binding and
catalyzes the nucleotide exchange reaction (Peyroche et al., 1996).
In addition to the Sec7 domain, ARF-GEFs contain large
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which are likely to be important for the localization and function of
ARF-GEF proteins. Two subfamilies of so-called large ARF-GEFs
are known, the Brefeldin-A-inhibited GEF (BIG) family proteins,
which act on recycling endosomes at the trans-Golgi, and the
Golgi-specific Brefeldin-A-resistant guanine nucleotide exchange
factor 1 (GBF1) family proteins, which act at the cis-Golgi
(reviewed by Anders and Jurgens, 2008; Zhao et al., 2002; Bui
et al., 2009). GBF1 family ARF-GEFs have been characterized in
yeast (Gea1/2) (Peyroche et al., 1996; Spang et al., 2001),
mammalian cells (GBF1) (Claude et al., 1999; Kawamoto
et al., 2002) and plants (GNOM, GNL1) (Richter et al., 2007).
Drosophila contains a single GBF1 homolog called gartenzwerg
(garz) (Kraut et al., 2001; Szul et al., 2011). However, garz loss-of-
function mutations were not available and it was not clear which of
the six annotated ARF-GEF homologs in Drosophila are involved
in COPI vesicle formation at the Golgi. Despite a wealth of studies
in cultured mammalian cells, very little is known about the
function of GBF1 family ARF-GEFs during animal development.
Here we describe the identification and functional characterization
of garz mutations. We show that garz is an essential gene that
is required for the morphogenesis of tubular epithelia during
embryogenesis. Furthermore, garz is required for normal Golgi
morphology and for localization of COPI components. Garz
localizes at the cis-Golgi complex, and this localization depends on
the C-terminal half of the Garz protein. We show that garz
interacts genetically with the ARF1 homolog ARF79F and with the
ARF1-GAP homolog Gap69C, thus placing garz in a regulatory
circuit that controls COPI trafficking in Drosophila. The results of
garz loss-of-function and gain-of-function experiments suggest
that garz regulates tracheal tube expansion by modulating the rate
of membrane flow between the Golgi and the ER.
Results
angina mutations affect tracheal tube expansion and
protein secretion in epithelia
In a mutagenesis screen for genes involved in tracheal tube
morphogenesis we isolated a lethal complementation group
consisting of five alleles, which showed defects in tracheal lumen
expansion (Fig. 1). Although early tracheal development was
normal in the mutants, the lumen of the tracheal dorsal trunk
(DT) failed to expand to its normal diameter and tracheal tubes
did not fill with gas (Fig. 1B,F and data not shown). All five
alleles showed similar tracheal defects and were embryonic
lethal. We named the locus angina (aga) based on the narrow
tracheal lumen phenotype. Besides the tracheae, other epithelial
structures were defective in aga embryos. The salivary glands
showed a narrower and bulbous lumen compared with those in
the wild type (Fig. 1K,O). The larval cuticle was weakly
pigmented and appeared transparent (Fig. 1L,P). Moreover,
dorsal closure was delayed, although the dorsal epidermis
eventually closed in most late-stage embryos. However, during
dorsal closure, aga mutants showed fewer filopodia in the
epidermal leading edge compared with wild-type embryos
(supplementary material Fig. S1).
Fig. 1. Effects of angina mutations on epithelial secretion and tubular organ development. (A–K,M–O) Projections of confocal Z-stacks showing tracheal
dorsal trunk (A–J,M,N) or salivary glands (K,O) in stage 16 wild-type (A–D, I–K) and aga mutant (E–H, M–O) embryos, respectively. (A–H) In wild-type
embryos (A–D) Verm–RFP (magenta in A,E) is secreted into the tracheal lumen. Tracheal cells are marked with GFP (green in A,E). The membrane proteins SAS
(magenta in C,G) and Fas III (green in C,G) localize to the apical and basolateral membrane, respectively. In aga mutant embryos (E–H) secretion of Verm–RFP
(F) and SAS (H) is impaired and the proteins are partially retained intracellularly. Localization of Fas III (green in G) is unaffected in aga mutants.
(I,J,M,N) Chitin (I) and Pio protein (J) accumulate in the tracheal lumen in stage 16 wild-type embryos. Deposition of chitin (M) and Pio (N) appear normal in
agaR1044/Df(2R)Exel6061 (referred to as agaR1044/Df) mutant embryos. Note that aga mutants show narrow tracheal lumina. (K,O) SAS staining (green) outlines
the salivary gland lumen, while lateral cell membranes are marked by Fas III (magenta). Note that the salivary gland lumen in aga mutants (O) is narrower
compared to the wild type (K). (L,P) Cuticle preparations of wild-type and agamutant embryos. Wild-type embryos (L) show pigmented ventral denticle belts and
head skeleton. aga mutants (P) show weak pigmentation of these structures. Scale bars: 10 mm (A–K,M–O), 100 mm (L,P).
















In addition to the morphological defects, aga mutations
affect protein secretion. Whereas Vermiform–RFP (Verm–RFP)
protein accumulated in the tracheal lumen and was not detectable
inside tracheal cells in wild-type stage 15 embryos (Fig. 1B),
Verm–RFP was partially retained in tracheal cells of aga mutants
(Fig. 1F). Similarly, endogenous Verm (Fig. 3A,B) and the
related secreted protein Serpentine (Serp; data not shown), and
the apical transmembrane (TM) protein Stranded at second (Sas;
Fig. 1D,H) (Schonbaum et al., 1992) were partially retained in
tracheal cells of aga mutants. By contrast, chitin was deposited
normally in the tracheal lumen (Fig. 1I,M). Similarly, the
localization of the zona pellucida protein Piopio (Pio)
(Jazwinska et al., 2003) in the lumen of the tracheae and
salivary glands appeared normal in aga mutants (Fig. 1J,N and
data not shown). Moreover, despite the effects on protein
secretion, aga mutations did not cause obvious defects in
epithelial polarity, because apical (Crumbs; data not shown)
and basolateral (Fasciclin III; Fig. 1C,G,K,O, supplementary
material Fig. S1) polarity markers localized correctly to the
corresponding membrane domains in tracheal, salivary gland, and
epidermal cells of aga mutants. Taken together, these findings
indicate a requirement of aga for protein trafficking and
morphogenesis in epithelial cells.
angina alleles carry mutations in the ARF-GEF gene
gartenzwerg
We mapped the aga locus to the cytological interval 48F5-49A6
by non-complementation of Df(2R)Exel6061 (Parks et al., 2004).
One gene in the interval, gartenzwerg (garz/CG8487; FlyBase)
(Kraut et al., 2001) encodes a GEF for ARF family G-proteins
involved in vesicle trafficking (Fig. 2). garz is a member of a
conserved family of ARF-GEFs with homologs in humans
(GBF1; 43% identity) (Claude et al., 1999), Caenorhabditis
elegans (GBF1; 34% identity; WormBase), Arabidopsis thaliana
(Gnom; 29% identity) (Busch et al., 1996) and Saccharomyces
cerevisiae (Gea1, Gea2; 20% and 19% identity, respectively)
(Spang et al., 2001). By sequencing the garz coding region, we
identified single point mutations in four of the five EMS-induced
aga alleles (garzW982, garzR1044, garzW1113, garzQ1427; Fig. 2A).
Each of these mutations results in a premature termination codon
located C-terminally to the Sec7 domain (Fig. 2B). Furthermore,
a P-element (EP2028; Fig. 2A) (Bellen et al., 2004) inserted 298
bp upstream of the annotated transcription start site of garz failed
to complement all our aga alleles. EP2028 homozygous embryos
showed tracheal defects resembling those of aga mutants (data
not shown). Finally, tracheal-specific expression of Garz or GFP–
Garz transgenes rescued the narrow tracheal lumen and the
secretion defects of aga embryos (Fig. 3C,E, and data not
shown). Together, these results indicate that the aga locus
corresponds to the garz gene. We therefore refer to aga as garz
from here on.
We found that in the EMS-induced garz alleles the
mutant mRNAs are detectable by semi-quantitative RT-PCR
(supplementary material Fig. S2), suggesting that these mutant
mRNAs, when translated, could give rise to C-terminally
truncated proteins. We cannot exclude that such truncated Garz
proteins could interfere with wild-type Garz or with other
proteins in a dominant-negative fashion. However, tracheal
Fig. 2. angina alleles carry mutations in the Sec7 domain protein Garz. (A) Genomic region of the garz locus. Positions of premature stop codons in four
EMS-induced garz mutations are indicated. garzW982 contains a G2946A nonsense mutation (W982.stop). garzR1044 contains a C3130T nonsense mutation
(R1044.stop). garzW1113 contains a G3338A nonsense mutation (W1113.stop). garzQ1427 contains a C4279T nonsense mutation (Q1427.stop). Nucleotide
positions of the mutations refer to the garz-RB cDNA. Coding exons are filled in black. EP2028 is a P-element insertion 298 bp upstream of the garz transcription
start site. Two alternatively spliced garz transcripts are predicted to give rise to two Garz protein isoforms of 1740 aa and 1983 aa, respectively, which differ in
their C-terminus. (B) Domain structure of Drosophila Garz and human GBF1 proteins. Numbers indicate percentage amino acid identity of the conserved motifs
DCB, HUS, HDS1, HDS2, HDS3, and the Sec7 domain between Drosophila Garz and human GBF1 proteins. The garzW982, garzR1044, garzW1113 and garzQ1427
mutations result in premature stop codons C-terminal to the Sec7 domain. Note that the Sec7 domain sequence is unchanged in all four garz alleles. (C–E) In situ
hybridization to detect garz transcripts in embryos. Maternal garz transcripts are detectable in freshly laid eggs (C). Zygotic garz transcripts are detectable at stage
11 with elevated levels in tracheal and salivary glands cells (D). From stage 14 onwards elevated levels of garz mRNA are detected in the epidermis (E).
















phenotypes of garzR1044 and garzW1113 homozygous embryos
were strictly recessive and were indistinguishable from the
phenotypes of embryos carrying these mutations in trans to
Df(2R)Exel6061 (Fig. 1E,F,M,N and data not shown). This
suggests that the mutations, despite the presence of the catalytic
Sec7 domain in the presumed truncated proteins, are strong or
complete loss-of-function alleles.
garz is expressed in embryonic epithelia
Consistent with a function in epithelial morphogenesis and
secretion, we found elevated levels of garz mRNA in epithelial
tissues during embryogenesis. Zygotic garz transcripts were first
detectable at stage 10 in the developing salivary gland (data not
shown). Salivary gland signals became stronger during germband
retraction and are maintained throughout embryogenesis
(Fig. 2D,E). garz expression in tracheal cells was detectable from
stage 11 onwards (Fig. 2D,E). From stage 14 on, garz transcripts
were also detectable in the epidermis (Fig. 2E). Maternal garz
mRNA is present in freshly laid eggs (Fig. 2C). Removal of garz
function from the female germline caused an early arrest in
oogenesis, indicating that garz function is essential for cell survival
or growth during oogenesis (data not shown). This finding further
suggests that perduring maternal garz gene products mask a
requirement of garz during early embryogenesis. Perdurance of
maternal garz gene products is therefore likely to account for the
late onset of the defects observed in zygotic garz mutants.
GFP–Garz localizes to the cis face of the Golgi complex
Drosophila Garz and its human homolog GBF1 were
proposed to participate in COPI vesicle trafficking between
the ER and the Golgi, as well as in endocytic uptake of
glycosylphosphatidylinositol-anchored proteins (GPI-APs) (Mayor
and Pagano, 2007; Gupta et al., 2009). To understand the role of
garz in more detail, we examined the subcellular localization of a
GFP–Garz fusion protein (Fig. 4). In transfected S2R+ cells, GFP–
Garz was enriched at perinuclear punctate structures, whereas
lower-level signals were distributed throughout the cytoplasm
(Fig. 4A). Punctate signals overlapped with the Golgi marker p120
(Fig. 4B,C) (Stanley et al., 1997). The GFP–Garz signals also
colocalized with the cis-Golgi matrix protein GM130 (Fig. 4D–F)
(Sinka et al., 2008) and largely overlapped with the cis-Golgi-
associated protein GMAP210 (Fig. 4G–I) (Friggi-Grelin et al.,
2006). In epidermal cells in living embryos, GFP–Garz was
enriched at punctate structures with lower levels distributed in the
cytoplasm (Fig. 4J–L). The GFP–Garz punctae overlapped with the
COPII component Sec31–RFP, which is enriched at ER exit sites
(ERES) (Fo¨rster et al., 2010) (Fig. 4K,L). By contrast, Sec31–RFP
punctae localized adjacent to, but not overlapping with the trans-
Golgi marker galactosyltransferase (GalT)–GFP (Fig. 4M–O).
Similarly, GalT–GFP signals were also adjacent to GMAP210
signals (Fig. 4P–R), indicating that our methods allow us to separate
cis- and trans-Golgi compartments. We measured the distances
between fluorescence intensity maxima of pairs of two markers at a
given Golgi stack in epidermal cells (Fig. 4S). GFP–Garz maxima
showed amean distance of 0.08±0.054 mm (n528) from Sec31–RFP
maxima. By contrast, Sec31–RFP maxima were at a significantly
greater distance from GalT–GFP maxima (mean distance
0.37±0.1 mm; n533; P50.0001) than from GFP–Garz maxima.
Although the resolution limit did not allow us to distinguish between
cis-Golgi and ERES, these results suggest that GFP–Garz is localized
in closer proximity to the cis-face of the Golgi and to ERES than to
the trans-Golgi compartment labeled by GalT–GFP. Whereas we
observed that GFP–Garz accumulated adjacent to Golgi or ERES
structures, we did not find GFP–Garz accumulations in proximity to
the early endosomal marker Rab4–RFP (data not shown). Taken
together, our data from S2 cells and embryos suggest that GFP–Garz
accumulates specifically at the cis-Golgi.
The C-terminal portion of Garz is required for Golgi
localization
All of our EMS-induced garz mutations are expected to give rise
to C-terminally truncated proteins, but leave the catalytic Sec7
domain intact. Thus, these garz mutations might interfere with
Golgi localization of the corresponding truncated proteins. To
investigate this possibility, we analyzed the localization of wild-
type and mutant GFP–Garz fusion proteins in tracheal cells and
in transfected S2 cells (Fig. 5). GFP–Garz accumulated at
the Golgi, whereas a fraction of the protein was distributed
throughout the cytoplasm (Fig. 5A–D). By contrast, a C-
terminally truncated protein corresponding to the garzW982
allele [GFP–Garz(W982)] failed to accumulate at the Golgi and
was instead uniformly distributed in the cytoplasm of tracheal
cells (Fig. 5E,F). Importantly, although GFP–Garz(W982) retains
Fig. 3. Human GBF1 can restore garz function in tracheal cells. (A) Verm
protein accumulates in the tracheal lumen in wild-type embryos. (B) In
garzR1044/Df(2R)Exel6061 (referred to as garzR1044/Df) embryos secretion of
Verm is impaired and the diameter of the tracheal lumen is smaller compared
with wild-type embryos. (C) Verm secretion and tracheal lumen dilation are
restored by tracheal-specific expression of garz under the control of btl-Gal4
in garzR1044/Df(2R)Exel6061 embryos. (D) Tracheal-specific expression of
human GBF1 rescues Verm secretion and lumen dilation in
garzR1044/Df(2R)Exel6061 embryos. (E) Quantification of tracheal dorsal
trunk luminal diameter in metamere 6 in wild-type, garzR1044/
Df(2R)Exel6061, and in garzR1044/Df(2R)Exel6061 embryos expressing
either garz or human GBF1 under the control of btl-Gal4. Lumen diameter in
garz embryos is significantly smaller than in wild-type embryos and in garz
mutant embryos expressing the garz or GBF1 rescue constructs
(***P,0.001; error bars indicate s.d.). A–D are confocal projections of the
tracheal dorsal trunk stained for Verm protein. Scale bar: 10 mm.
















the catalytic Sec7 domain, expression of GFP–Garz(W982) failed
to rescue the defects in garz mutants (data not shown) and
expression in a wild-type background did not interfere with garz
function (Fig. 5F). These results suggest that the C-terminal half
of Garz contains signals that are essential for localization of the
protein to the Golgi, and that the defects in garz embryos are due
to the failure of the mutant proteins to localize correctly.
The ARF-GEF catalytic center is crucial for Golgi
localization and function of Garz
The requirement of the C-terminal part of Garz for Golgi
localization was somewhat surprising because the cycling of
GBF1 between a cytoplasmic and a Golgi-membrane-associated
pool was reported to depend on the nucleotide exchange reaction
mediated by the Sec7 domain (Garcia-Mata et al., 2003; Niu
et al., 2005; Zhao et al., 2006). To test whether more than one
part of Garz is required for Golgi localization, and whether Garz
localization also depends on ARF-GEF activity, we examined the
localization of a mutant Garz protein, GFP–Garz(E740K). The
E740K amino acid substitution in the catalytic center is presumed
to abolish the nucleotide exchange reaction, as was shown for the
corresponding mutations in the Sec7 domain of the human
ARF-GEFs ARNO(E156K) (Beraud-Dufour et al., 1998) and
GBF1(E794K) (Garcia-Mata et al., 2003). GFP–Garz(E740K)
was localized predominantly at the Golgi in tracheal cells and in
S2 cells, whereas cytoplasmic signals were strongly reduced
compared with the distribution of wild-type GFP–Garz (Fig. 5I–
L). Strikingly, tracheal expression of GFP–Garz(E740K) caused
strong defects in apical secretion of Verm–RFP and in tracheal
lumen dilation (Fig. 5J). The effect of GFP–Garz(E740K) on
Verm–RFP secretion was reminiscent of the defects observed
in garz loss-of-function mutants, but more severe in strength
(Fig. 1E,F, Fig. 5J). These results suggest that GFP–
Garz(E740K) interferes with the function of ARF G-proteins,
possibly through a dominant-negative effect due to sequestration
of ARF (Garcia-Mata et al., 2003; Szul et al., 2005) or titration of
other Garz binding partners. Accordingly, GFP–GarzE740K is
expected to interfere both with maternal and zygotic Garz protein
pools, thus explaining the more severe phenotype than in zygotic
garz mutants. We conclude that the activity and localization of
Garz depend on the GDP-GTP exchange reaction mediated by
the Sec7 domain, which is consistent with the notion that garz
functions as an ARF-GEF. This conclusion is further supported
by our finding that human GBF1 protein rescues the tube
expansion and secretion defects of garz mutants (Fig. 3D,E).
Similar GFP–Garz, HA-tagged GBF1 protein localizes to
Fig. 4. GFP–Garz localizes to the cis-Golgi complex. (A–C) S2 cells transfected with GFP–Garz (upper cell) and stained for GFP (green in C), the Golgi protein
p120 (magenta in C), and DNA (blue in C). GFP–Garz localizes to p120-positive Golgi stacks. The lower cell was not transfected. (D–I) S2 cells transfected with
GFP–Garz and stained for GFP (D,G; green in F,I) and either the cis-Golgi marker GM130 (E, magenta in F) or the cis-Golgi microtubule-associated protein
GMAP210 (H; magenta in I). Note that GFP–Garz colocalizes with GM130 and largely overlaps with GMAP210. (J–R) Confocal sections of stage 15 epidermal
cells in living (J–O) or fixed (P-R) embryos expressing GFP–Garz and the ER exit site marker Sec31–RFP (J–L) or Sec31–RFP and the trans-Golgi marker GalT–
GFP (M–O). Sec31–RFP (K; magenta in L) signals overlap with GFP–Garz (J; green in L). By contrast, GalT–GFP (M; green in O) accumulates in close
proximity, but non-overlapping with Sec31–RFP (N; magenta in O). GalT–GFP signals localize adjacent to, but do not overlap with GMAP210 (Q; magenta in R).
(S) Bar diagram showing mean distances between fluorescence intensity maxima of GFP–Garz and Sec31–RFP or GalT–GFP and Sec31–RFP, respectively,
measured in epidermal cells of living embryos. Error bars indicate s.d. Scale bars: 5 mm.
















GM130-positive cis-Golgi structures in Drosophila S2 cells
(supplementary material Fig. S3). Furthermore, as in mammalian
cells, the E794K mutation leads to increased accumulation of
GBF1 at the Golgi (supplementary material Fig. S3) (Garcia-
Mata et al., 2003). These results suggest that ARF-GEF function
and the mechanism of localization to the Golgi membrane are
conserved between Drosophila Garz and human GBF1.
garz is required for correct localization of COPI
components and for Golgi morphology
The human Garz homolog GBF1 plays a key role in COPI vesicle
formation by recruiting and activating ARF1 at the cis-Golgi
(Claude et al., 1999; Kawamoto et al., 2002; Zhao et al., 2002).
To determine whether garz plays a similar role in Drosophila, we
examined effects of garz mutations on the Golgi using markers
for different Golgi compartments. A GFP fusion protein of the
ARF1 homolog ARF79F (Shao et al., 2010) was enriched at
Golgi stacks, whereas a fraction of the protein was uniformly
distributed throughout the cytoplasm (Fig. 6A). In garz mutants,
punctate localization of ARF79F–GFP was lost, and signals were
instead distributed throughout the cytoplasm with few large GFP-
positive dots (Fig. 6B), indicating that garz is required for
ARF79F localization at the Golgi membrane. Consistent with the
effect on ARF79F localization, garz function was also required
for accumulation of the COPI coat subunit b9-COP in a punctate
pattern in epidermal cells (Fig 6E,F) (Stempfle et al., 2010).
Although b9-COP distribution was diffuse in garz mutant cells,
b9-COP accumulation was rescued by expression of GFP–Garz in
stripes of epidermal cells (Fig. 6F). Finally, to address effects on
the trans-Golgi network (TGN), we analyzed the distribution of
the trans-Golgi marker GalT–GFP. Tracheal cells in wild-type
stage 15 embryos contained multiple Golgi stacks labeled by
GalT–GFP (Fig. 6C). By contrast, in garz mutants, GalT–GFP
was diffuse and larger aggregates were observed, suggesting that
the TGN becomes dispersed and Golgi aggregates are formed
(Fig. 6D). Taken together, these results indicate that garz
function is essential for the correct localization of the ARF1
homolog ARF79F and of COPI coatomer components, as well as
for the normal organization of the Golgi complex.
garz interacts genetically with the ARF1 homolog ARF79F
and the ARF1-GAP homolog Gap69C
Given the essential requirement of garz for ARF79F localization,
we asked whether garz interacts genetically with the ARF G-
protein machinery. To address this, we made use of a dominant
phenotype caused by overexpression of Garz in the eye (Kraut
et al., 2001; Raghu et al., 2009). Overexpression of Garz or GFP–
Garz in the developing eye (using the GMR-Gal4 driver) causes a
‘rough’ eye phenotype, presumably because of overactivation of
one or more ARF proteins (supplementary material Fig. S4).
Consistent with this idea, co-overexpressing ARF79F–GFP
with Garz or GFP–Garz enhanced the rough eye phenotype,
whereas expression of ARF79F–GFP alone had no effect on
eye morphology (supplementary material Fig. S4). Conversely,
overexpression of Gap69C, a negative regulator of ARF79F
(Raghu et al., 2009), suppressed the effect of garz overexpression
in a similar manner to the suppression observed with garz RNAi
as a control. By contrast, expression of a Gap69C RNAi construct
enhanced the garz overexpression phenotype. We tested whether
the garz overexpression effect could be suppressed by reducing
Fig. 5. The Garz C-terminal half and the Sec7 domain catalytic site are required for normal subcellular distribution of Garz. (A,B,E,F,I,J) Confocal
sections of tracheal dorsal trunk in living stage 15 embryos co-expressing Verm–RFP (magenta) and different versions of GFP–Garz (green). (C,D,G,H,K,L) S2
cells transfected with the corresponding GFP–Garz versions were stained for GFP (green) and the cis-Golgi marker GM130 (magenta). (A–D) GFP–Garz
(green) accumulates in distinct punctae, whereas a fraction of the protein is distributed throughout the cytoplasm in tracheal cells (A,B). The expression of
GFP–Garz in stage 15 embryos carrying one copy of btl-Gal4 does not interfere with Verm–RFP secretion or lumen dilation. In transfected S2 cells
(C,D) GFP–Garz overlaps with the cis-Golgi marker GM130 (magenta in D). Note that in tracheal cells and in S2 cells a fraction of GFP–Garz is distributed
throughout the cytoplasm. (E–H) A truncated version of GFP–Garz (GFP–GarzW982; green) lacking the 1001 C-terminal amino acids shows no punctate
localization and is instead distributed throughout the cytoplasm in tracheal cells (E,F). In transfected S2 cells, the truncated protein appears to accumulate in
aggregates that do not colocalize with GM130 (G,H). (I–L) GFP–Garz-E740K carrying a mutation in the Sec7 domain catalytic site accumulates exclusively in Golgi
punctae, whereas the cytoplasmic signals are strongly reduced, both in tracheal (I,J) and in S2 cells (K–L). Scale bars: 10 mm (A,B,E,F,I,J) and 5 mm (C,D,G,H,K,L).
















the dosage of specific ARF or ARL family G-proteins through
RNAi. We tested RNAi constructs (Dietzl et al., 2007) to target
ARF79F (the homolog of mammalian ARF1/3) (Gillingham and
Munro, 2007), ARF102F (the homolog of mammalian ARF4/5),
ARF72A (the homolog of mammalian ARL1), ARF84F (the
homolog of mammalian ARL2), CG2219 (the homolog of
mammalian ARL4), CG7735 (the homolog of mammalian
ARL6), or CG7039 (the homolog of mammalian ARP1). With
the exception of ARF79F, expression of these RNAi constructs in
the eye did not lead to a modulation of the Garz overexpression
phenotype (data not shown). ARF79F RNAi caused pupal
lethality, thus preventing us from analyzing interactions
between ARF79F and garz by RNAi. However, the modulation
of the garz overexpression phenotype by ARF79F and Gap69C
overexpression is consistent with the idea that Garz functions by
activating ARF79F.
garz overexpression leads to ER retention and tube
dilation defects
We also examined the effect of garz overexpression during
embryonic tracheal development. Interestingly, although tracheal-
specific expression of UAS-Garz or UAS–GFP–Garz rescued the
tracheal lumen dilation and secretion defects of garz mutant
embryos (Fig. 3C,E; data not shown), elevated expression (using
two copies of btl-Gal4) of the same transgenes in a wild-type
background led to defects reminiscent of the garz loss-of-function
phenotype (Fig. 7C,E). Verm–RFP accumulated in tracheal cells
and luminal diameter was significantly narrower than in wild-type
embryos (Fig. 7G). Intracellular Verm–RFP localized in a
perinuclear pattern (Fig. 7E) and colocalized with an ER marker
(anti-KDEL; data not shown), suggesting that upon garz
overexpression, Verm–RFP accumulates in the ER. This might
be explained by an interaction of the overexpressed Garz protein
with endogenous Garz or with other proteins in a dominant-
negative fashion. However, both UAS–Garz and UAS–GFP–Garz
were functional in a rescue assay (Fig. 3 and data not shown).
Furthermore, garz overexpression led to enhanced punctate
accumulation of ARF79F–GFP, whereas cytoplasmic ARF79F–
GFP signals were reduced compared with levels in the wild type
(Fig. 7B,F), suggesting that recruitment of ARF79F–GFP to the
Golgi membrane was increased. By contrast, in garz mutants, the
punctate localization of ARF79F–GFP was almost completely lost
(Fig. 7D). These findings suggest that the secretion and tube
dilation defects upon garz overexpression are not due to defective
Golgi function or Golgi disassembly, but are rather due to
increased ARF-GEF-dependent trafficking.
Discussion
We have described the function of the Sec7 domain protein Garz
in epithelial tube development during Drosophila embryogenesis.
We show that garz is essential for tracheal tube expansion and for
epithelial protein secretion. Garz protein localizes to the Golgi
and is required for normal Golgi morphology and for correct
localization of COPI components. Garz is a member of the
conserved Sec7-domain-containing family of large ARF-GEF
proteins, which are involved in membrane-budding events at
different intracellular compartments. Two families of large ARF-
GEFs are known, the BIG and the GBF1 families. BIG1 and
BIG2 localize to the TGN (BIG1 and BIG2) (Zhao et al., 2002) or
recycling endosomes (BIG2) (Shin et al., 2004), where they
facilitate recruitment of clathrin coat proteins. By contrast, GBF1
acts at the cis-Golgi membrane, where it initiates COPI vesicle
formation by activating a class I ARF protein (Kawamoto et al.,
2002; Garcia-Mata et al., 2003). Six different Sec7 domain
proteins are encoded in the Drosophila genome. Although the
functions of some of these ARF-GEFs have been studied using
genetic approaches, mutations in garz, the single GBF1 family
homolog in Drosophila, have not been described thus far. The
garz gene was identified by virtue of its effects on axon guidance
and eye development upon overexpression in the nervous system
(Kraut et al., 2001; Shulman and Feany, 2003; Raghu et al.,
2009). A recent study using tissue-specific RNAi showed that
garz is required for normal development of the salivary glands
(Szul et al., 2011). Here we describe the identification and
characterization of garz loss-of-function mutations. We provide
functional evidence that garz regulates tracheal tube expansion
and secretion by acting as an ARF-GEF at the cis-Golgi. First, we
show that Garz protein is distributed throughout the cytoplasm,
whereas a fraction of the protein accumulates at the Golgi.
Similarly, mammalian GBF1 protein dynamically cycles between
cytoplasmic and Golgi membrane-associated pools (Niu et al.,
2005; Zhao et al., 2006). Second, a catalytic site mutation that
interferes with the nucleotide exchange reaction abolishes Garz
Fig. 6. garz is required for the correct localization of COPI components
and for Golgi morphology. (A–D) Confocal sections of tracheal dorsal trunk
in living embryos expressing ARF79F–GFP (A,B) or GalT–GFP (C,D) in
tracheal cells under the control of btl-Gal4. (A,B) In wild-type embryos (A),
ARF79F–GFP accumulates in punctae, while a fraction of the protein is
distributed throughout the cytoplasm. In garz mutant embryos (B) ARF79F–
GFP punctate localization is lost and the protein is instead distributed
throughout the cytoplasm. (C,D) In wild-type embryos (C), the trans-Golgi
marker GalT–GFP localizes to discrete punctae in tracheal cells. In garz
mutant embryos (D) punctate localization of GalT–GFP is abolished and
GalT–GFP is instead distributed uniformly with few large GFP-positive dots,
which might represent Golgi aggregates. (E,F) The COPI coat protein b9-COP
(magenta in E) was detected by immunostaining in epidermal cells expressing
GFP–Garz (green in E) in stripes of cells under the control of prd-Gal4. Note
that in GFP–Garz-expressing (rescued) cells b9-COP is localized in discrete
punctae, whereas b9-COP localization is more diffuse in garzmutant cells that
do not express GFP–Garz. The green dashed line in F marks the border
between GFP–Garz-expressing (rescued) and non-expressing mutant cells.
Scale bars: 10 mm.
















function and leads to constitutive accumulation of Garz at the
Golgi, suggesting that Garz function and subcellular distribution
depend on GEF activity. Finally, we show that human GBF1 can
substitute for garz function in Drosophila tracheal tube expansion
and secretion, indicating that the relevant functions of Garz and
GBF1 proteins have been evolutionarily conserved. Although
GEF activity on ARF1 was shown to mediate the association of
GBF1 with the Golgi membrane, it has been an open question
how GBF1 protein initially gets recruited to the Golgi. The
conserved regions outside the Sec7 domain are thought to play an
important role in GBF1 localization. Our findings provide genetic
evidence supporting an essential requirement of the C-terminal
part of Garz protein for localization at the Golgi. The sequences
missing in the truncated GFP–Garz(W982) version include the
three conserved HDS motifs, suggesting that these motifs might
be involved in recruitment of Garz to the Golgi. This is consistent
with earlier work showing that a similar C-terminal truncation of
human GBF1 protein also abolished the Golgi localization of
GBF1 (Pan et al., 2008). Our finding that human GBF1 localizes
to the Golgi in Drosophila cells and is able to rescue garz mutant
phenotypes suggests that a conserved mechanism mediates
localization of ARF-GEFs at the cis-Golgi in flies and
mammals. Which interacting proteins are involved in localizing
Garz to the Golgi? The HDS1 motifs of yeast Gea1 and Gea2
proteins were shown to physically interact through a conserved
leucine residue with the Golgi membrane protein Gmh1 (Gea1-6
membrane-associated high-copy suppressor) (Chantalat et al.,
2003). This leucine residue is conserved in human GBF1 (L987)
and Drosophila Garz (L932), and is missing in the truncated Garz
and GBF1 versions. However, although Gmh1 was shown to
participate in the association of Gea proteins with membranes, it
is not absolutely required for Gea2 localization at the Golgi
(Chantalat et al., 2003). Thus, identification of other interacting
proteins that mediate Golgi localization will be important to
understand the function of Garz. A recent report implicated
GBF1 and Garz in endocytic uptake of GPI-anchored proteins
by a GPI-AP enriched early endosomal compartment (GEEC)
(Gupta et al., 2009). Although we did not observe accumulations
of GFP–Garz outside Golgi-positive spots in epithelial cells, the
broadly distributed cytoplasmic signals might obscure
localization of GFP–Garz at GEEC endosomes. Thus, our
results do not exclude a dual role of Garz in COPI vesicle
formation at the cis-Golgi and in GEEC endocytosis.
On which G-protein(s) does the Garz ARF-GEF act? Our
results suggest that Garz acts on the Drosophila ARF1 homolog
ARF79F, because accumulation of ARF79F–GFP at the Golgi
requires garz function and garz interacts genetically with
ARF79F and with Gap69C, a negative regulator of ARF79F.
Consistent with this notion, overexpression of garz causes the
redistribution of ARF79F–GFP from the cytoplasm towards a
Golgi-localized pool. Similarly, overexpression of GBF1 in HeLa
cells was reported to result in increased levels of ARF1–GTP
(Honda et al., 2005). Taken together, our findings suggest that
Garz regulates COPI vesicle formation as a rate-limiting factor
for the recruitment and activation of the ARF1 homolog
ARF79F, which is analogous to the roles of GBF1 and ARF1
in mammalian cells (Niu et al., 2005).
What is the role of garz in tracheal tube expansion? The
tracheal tube dilation and secretion defects observed in garz
mutants resemble the phenotype of mutants defective in COPI or
COPII vesicle formation (Tsarouhas et al., 2007; Grieder et al.,
2008; Jayaram et al., 2008; Fo¨rster et al., 2010; Norum et al.,
2010). However, garz mutants exhibit weaker tracheal defects
than cCOP mutants, and certain proteins, such as Pio, whose
secretion is affected in cCOP mutants, appear unaffected in garz
mutants (Grieder et al., 2008; Jayaram et al., 2008). This might
be due to cargo-specific effects of the garz mutations, as was
previously described for human GBF1 protein (Szul et al., 2007).
Fig. 7. Overexpression of garz causes tracheal lumen dilation and secretion defects resembling garz loss-of-function mutants. (A–F) Confocal sections of
tracheal dorsal trunk of wild-type embryos (A,B), garz mutant embryos (C,D), and embryos overexpressing garz in tracheal cells (E,F). Whereas Verm–RFP is
secreted into the tracheal lumen in wild-type embryos (A), Verm–RFP is retained intracellularly both in garz loss-of-function mutants (C) and in embryos
overexpressing garz in tracheal cells under the control of two copies of btl-Gal4 (E). Note that garz mutants and garz overexpressing embryos show narrow
tracheal lumina. (B,D,F) In wild-type embryos (B) ARF79F–GFP is localized in punctae, whereas a fraction of the protein is distributed in the cytoplasm. In garz
mutants (D) punctate localization of ARF79F–GFP is abolished. Conversely, in garz overexpressing embryos (F) ARF79F–GFP accumulates exclusively in
punctae, whereas cytoplasmic signals are reduced. Scale bars: 10 mm. (G) Quantification of tracheal lumen diameter in dorsal trunk metamere 6. Luminal
diameter in garz mutant and garz overexpressing embryos is significantly narrower compared with the wild type (***P,0.001; error bars indicate s.d.).
















Alternatively, perdurance of maternal garz gene products might
partially mask the zygotic requirement of garz, resulting in an
attenuated phenotype. Consistent with this idea, we showed that
expression of dominant-negative garzE740K, which is expected to
interfere with both maternal and zygotic Garz pools, causes more
severe tracheal defects than those observed in zygotic garz
mutants.
How does compromised COPI trafficking lead to defects in ER
export? The retention of secreted proteins in the ER in garz
mutants could be a secondary consequence of breakdown of the
Golgi complex, resulting in reduced retrieval of ER-resident
proteins. This might cause a block of ER export that is similar to
that seen in COPII mutants (Tsarouhas et al., 2007; Fo¨rster et al.,
2010; Norum et al., 2010). Alternatively, COPI vesicles might
play a more direct role in the exit of secreted proteins from the
Golgi. Interestingly, COPI-dependent exit of vesicles from
the Golgi is required for expansion of the autophagosomal
phagophore, a large membrane structure in yeast (van der Vaart
et al., 2010). garz could be acting in a similar fashion by
mediating the supply of Golgi-derived membrane material for
apical plasma membrane growth during tracheal tube expansion.
In both scenarios, compromised ARF-GEF-dependent trafficking
leads to a reduction in the rate of apical membrane growth.
Our results suggest that the ARF-GEF Garz controls epithelial
secretion and tracheal tube size by regulating membrane
trafficking between the Golgi and the ER. To maintain the
integrity and activity of the secretory apparatus, bidirectional
membrane transport between these compartments has to be
balanced. Under normal conditions GEFs are thought to be rate
limiting for the initiation of vesicle formation. Thus, the effects
of garz overexpression in tracheal cells and in the eye could
be caused by hyperactivation of COPI retrograde trafficking.
Similarly, overexpression of KDEL receptor was shown to cause
the redistribution of Golgi-resident proteins to the ER (Hsu et al.,
1992). By analogy, elevated retrograde trafficking in garz-
overexpressing tracheal cells could reduce the rate of exocytosis
through increased retrieval of proteins from the Golgi back to the
ER, instead of passing through the Golgi. This could limit the
supply of membrane material to the apical surface, resulting
in narrow tracheal tubes. Although we cannot exclude the
possibility that garz overexpression affects the Golgi in ways
other than by triggering COPI vesicle trafficking, we did not
observe obvious defects in Golgi morphology in garz-
overexpressing cells. Furthermore, the garz overexpression
phenotype in the eye is modulated by the dosage of a negative
ARF regulator, Gap69c, suggesting that the overexpression
effects are indeed due to elevated ARF activity. Thus,
regulating the rate of COPI vesicle trafficking by changing the
levels or activity of an ARF-GEF could provide a mechanism to
control the rate of exocytosis. This might play an important
role during epithelial morphogenesis, which involves dynamic
membrane growth and remodeling.
Materials and Methods
Drosophila strains
The garz alleles garzW982, garzR1044, garzW1113, garzQ1427 and garz233 were
isolated in an ethylmethanesulfonate mutagenesis screen. Mutations were induced
on a btl-Gal4 UAS-GFP UAS-Verm-mRFP chromosome (Fo¨rster et al., 2010) and
were balanced over the CyO Dfd-YFP chromosome (Le et al., 2006). Germline
clones were generated as previously described (Luschnig et al., 2004).
The following fly stocks were used: garzEP2028 (Spradling et al., 1999),
Df(2R)Exel6061 (Parks et al., 2004), UAS-ARF79F-GFP (Shao et al., 2010),
UAS-GalT-GFP (Snapp et al., 2004), UAS-Sec31-RFP (Fo¨rster et al., 2010), UAS-
Gap69C (Raghu et al., 2009), btl-Gal4 (Shiga et al., 1996), UAS-lacZRNAi (gift
from Peter Gallant, Biocenter, University of Wu¨rzburg, Wu¨rzburg, Germany),
UAS-Rab4-mRFP, 69B-Gal4 and GMR-Gal4 (Bloomington Stock Center). The
following UAS-RNAi lines were obtained from the Vienna Drosophila Research
Center (Dietzl et al., 2007): UAS-garzRNAi (VDRC 42140), UAS-Arf79FRNAi
(VDRC 23082), UAS-Arf72ARNAi (VDRC 17826), UAS-Arf102FRNAi (VDRC
12931), UAS-Arp1RNAi (VDRC 26007), UAS-Arl4RNAi (VDRC 41690), UAS-
Arl6RNAi (VDRC 43508) and UAS-Gap69CRNAi (VDRC 26460, 107069).
Tissue culture
Drosophila S2R+ cells were cultured in Schneider’s medium (Invitrogen) and
incubated at 27 C˚. For transfections, cells were seeded on coverslips in 24-well
plates. Culture medium was replaced after 24 hours and cells were transfected with
1 mg plasmid DNA using FuGene HD transfection reagent (Invitrogen). 24 hours
after transfection, cells were fixed with 4% formaldehyde and stained with
antibodies and Hoechst 33342.
Molecular biology
Genomic DNA was prepared from homozygous garz embryos. Coding exons of
the CG8487 gene, including exon–intron boundaries, were amplified by PCR. PCR
products were purified and the entire garz coding region was sequenced on both
strands (oligonucleotide sequences available on request).
Transgenic constructs were generated as follows. UAS-GFP-Garz: the EGFP
coding sequence was inserted between the EcoRI and NotI sites of pUAST-attB
(Bischof et al., 2007) to generate pUAST-attB-EGFP. The CG8487-PB coding
region was amplified from the genomic BAC clone BACR37I09 (BACPAC
Resources) using oligonucleotides KA16-NotI-F (ATAGCGGCCGCCATGGC-
GCTTCCAGGCAAC) and KA17-XbaI-R (ATATCTAGATCTTCACTGCT-
GGCCGTAGAG). The PCR product was digested with NotI and XbaI and
inserted into pUAST-attB-EGFP to generate pUAS-attB-EGFP-Garz. UAS-garz:
the GFP fragment from pUAST-attB-EGFP–Garz was excised by digestion with
EcoRI and NotI. Overhangs were filled-in using Klenow DNA polymerase and
the plasmid was re-ligated to generate pUAST-attB-garz. pUAST-attB-GFP-
Garz(W982): the GFP-tagged N-terminal portion of the garz coding sequence
corresponding to the garzW982 allele was amplified from pUAST-attB-EGFP-Garz
using oligonucleotides Ras42 (59-CGAATTCATGGTGAGCAAGGGCGAG-39)
and XbaIW982 (59-ATCATCTAGATCAGCTCTCTCTTAAGCAATC-39), which
contains the nonsense mutation of the garzW982 allele (underlined). The PCR
product was digested with EcoRI and XbaI and inserted into pUAST-attB. pUAST-
attB-GFP-Garz(E740K): the E740K point mutation was introduced by fusion PCR.
Two PCR fragments were amplified using overlapping oligonucleotides containing
the mutation (underlined; KA49, 59-AAGGCTCCATTGATCTTTTTGGT-39
and KA50, 59-AGATCAATGGAGCCTTTCCGGGCAATCTGAA-39). The 59
fragment of garz was amplified with KA16 and KA50, the 39 fragment with
KA49 and KA17. The resulting two fragments were joined by PCR using
oligonucleotides KA16 and KA17. The PCR product was digested with NotI and
XbaI and inserted into pUAST-attB-EGFP. pUAST-attB-HA-GBF1 and pUAST-
attB-HA-GBF1(E794K): wild-type and E794K mutant cDNAs of human GBF1
carrying an N-terminal HA tag (HA-GBF1 and HA-GBF1-E794K) in the p5/TO
vector were obtained from Paul Melancon (Department of Cell Biology, University
of Alberta, Edmonton, Canada). The cDNAs were excised using KpnI and XbaI
and inserted into pUAST-attB.
All PCR-amplified portions of the constructs were confirmed by DNA
sequencing. pUAST–GFP–Garz was inserted into the attP landing site 86Fa on
the third chromosome using WC31 integrase (Bischof et al., 2007). All other
pUAST-attB transgenes were inserted into the attP landing site P2 at 68A4 on the
third chromosome (Groth et al., 2004).
RT-PCR
Total RNA was extracted from 40 embryos (stage 16) per genotype using Trizol
(Invitrogen). RNA was treated with DNaseI to remove residual genomic DNA.
First-strand cDNA was generated using M-MuLV Reverse Transcriptase
(Fermentas) and random hexamer and oligo-dT primers. Subsequent PCR (30
cycles) was performed using oligonucleotides that bind in exons 8 and 10
of the garz transcript. A fragment of the gfat2 (glutamine:fructose-6-phosphate
aminotransferase 2; CG1345) transcript was co-amplified as an internal standard.
In situ hybridization
In situ hybridization was carried out according to standard procedures (Tautz and
Pfeifle, 1989). To generate the garz antisense RNA probe, a 2 kb fragment from
exons 7 and 8, including intron 7 (57 bp), was amplified from genomic DNA using
oligonucleotides KA7-F (59-TTATCAGCTCGGAGGGTCAG-39) and KA15-T7-
R (59-TAATACGACTCACTATAGGGAGCGAAACCGCTGGAGTAAT-39). The
reverse primer contained the T7 RNA polymerase promoter (underlined).
Digoxigenin-labeled probes were generated by in vitro transcription with
digoxigenin-labeled UTP (Roche) and detected using alkaline phosphatase-
conjugated anti-digoxigenin Fab fragments (1:2000; Roche).

















Homozygous embryos were collected by scoring for the absence of YFP
expression from the CyO Dfd-YFP balancer chromosome (Le et al., 2006).
Embryos were dechorionated, mounted in Hoyer’s medium and lactic acid (1:1),
and incubated for 2 hours at 65 C˚.
Immunofluorescence
The following antibodies were used: rabbit anti-Serp (1:300) (Luschnig et al.,
2006), rabbit anti-Verm (1:300) (Luschnig et al., 2006), guinea pig anti-Verm
(1:500) (Wang et al., 2006), rabbit anti-Pio (1:20) (Jazwinska et al., 2003), rabbit
anti-b’-COP (1:5000) (Stempfle et al., 2010), rabbit anti-GBF1 (1:1000) (Zhao
et al., 2006), rabbit anti-GM130 (1:1000; Abcam), mouse-anti-GFP (1:500;
Clontech), rabbit anti-GFP (1:500; gift from Stefan Heidmann, Department of
Genetics, University of Bayreuth, Bayreuth, Germany), rabbit anti-mRFP (1:2500;
gift from Stefan Heidmann), mouse anti-Golgi p120 (7H6D7C2; 1:250;
Calbiochem), mouse anti-KDEL (10C3; 1:10; Abcam), rabbit anti-SAS (1:250;
gift from Doug Cavener, Department of Biology, Pennsylvania State University,
PA), mouse anti-Fasciclin III (7G10; 1:50; DSHB), rabbit anti-GMAP210 (1:400;
Friggi-Grelin et al., 2006), rabbit anti-HA (1:300; Roche). Rhodamine- or FITC-
conjugated chitin binding probe (1:100; New England Biolabs) was used to detect
chitin. Primary antibodies were detected using secondary antibodies conjugated
with Alexa Fluor 568, Alexa Fluor 488 (Molecular Probes) or Cy5 (Jackson
ImmunoResearch). Embryos were fixed in 4% formaldehyde in PBS/heptane for
20 minutes and devitellinized by shaking in methanol and heptane. Stained
embryos were mounted in Prolong Gold antifade medium (Invitrogen). Although
GFP–Garz punctae were preserved after fixation of S2 cells, punctate signals were
lost during formaldehyde or methanol fixation of embryos. Localization of GFP–
Garz in embryos was therefore only analyzed in living specimens.
Quantitative analysis of Garz subcellular localization
Localization of GFP–Garz was analyzed in epidermal cells of living stage 15
embryos using 69B-Gal4 to drive expression of UAS–Sec31–mCherry either with
UAS–GFP–Garz or with UAS–GalT–GFP. Confocal images were analyzed using
ImageJ (v1.42). Distances were measured by drawing a line through the intensity
maxima of adjacent spots using the Plot Profile tool. Spots were pre-selected to
show similarly strong signals in both channels.
Light microscopy
Imaging of S2 cells was performed using either a Zeiss Cell Observer microscope
equipped with a 1006/1.4 NA oil lens and a CCD camera (AxioCam MRm) or an
Olympus FV1000 confocal microscope equipped with a 488 nm Argon and a 559/
635 nm diode Laser and 406/1.3 NA and 606/1.35 NA objectives. Z-stacks were
processed using Huygens Deconvolution (SVI) and ImageJ (v1.42; NIH) software.
For live imaging experiments embryos were dechorionated and mounted in
Voltalef 10S oil. Tracheal lumen diameter was measured in stage 16 embryos at
three defined positions in dorsal trunk metamere 6 as previously described (Fo¨rster
et al., 2010) and values were averaged.
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